Rejuveron Life Sciences AG

Rejuveron Life Sciences AG is a Baar, Switzerland-based venture-style life sciences investor and therapeutics builder focused on aging-related diseases. It develops and invests in therapies targeting the hallmarks of aging, with portfolio themes including ophthalmology, senescence, fibrosis, telomere restoration, vascular and cognitive programs. The firm is relevant for early-stage therapeutics founders in biotechnology, life sciences, pharmaceuticals, oncology and adjacent medical-device or healthtech areas.